PUBLISHER: KuicK Research | PRODUCT CODE: 1531957
PUBLISHER: KuicK Research | PRODUCT CODE: 1531957
India Cancer Diagnostics Test Market, Test Price By Indication & Future Outlook 2028
India Cancer Diagnostics Test Market, Test Price By Indication & Future Outlook 2028 Report Offering:
- India Cancer Diagnostic Tests Market Opportunity: > US$ 250 Million
- India Cancer Diagnostic Tests Market Current & Future Scenario
- Cancer Diagnostic Tests Market Business Models In India
- India Cancer Diagnostic Tests Market Size (2024 -2028) By Indications
- Cancer Diagnostic Tests Availability & Pricing By Indications, Labs/Hospitals & City
- Multiple Antigen Test Costs By Indications, Market & Labs/Hospitals
- Estimated Cancer Cases (2024 -2028) By Indication
The need for cancer diagnostic tests in India is both significant and urgent. With a population exceeding 1.4 Billion, the country faces unique challenges in providing comprehensive cancer care. Many cases are diagnosed at late stages due to a combination of factors including lack of awareness, limited access to healthcare facilities and financial constraints. Improved availability and accessibility of diagnostic tests could lead to earlier detection and, consequently, better treatment outcomes for patients across the country. India's cancer diagnostic tests market is experiencing rapid growth, driven by the rising incidence of cancer in the country and increasing awareness about the importance of early detection. Cancer has become a major public health concern in India, with over 1 Million new cases diagnosed annually and around 900,000 deaths per year. This situation underscores the critical need for effective and accessible diagnostic tests across the nation.
Among the most prominent cancers in India are breast cancer, oral cancer, cervical cancer, lung cancer, colorectal cancer and stomach cancer. Each of these cancer types requires specific diagnostic test approaches, contributing to the complexity of the cancer diagnostic landscape in India.
A wide range of diagnostic tests are available for these cancers, including imaging tests such as X-rays, CT scans, MRI scans, PET scans and ultrasounds. Endoscopy procedures like colonoscopy, bronchoscopy and upper endoscopy are also commonly used. Biopsy methods, including fine-needle aspiration, core needle biopsy, and surgical biopsy, play crucial role in definitive diagnosis. Blood tests, such as complete blood count, tumor marker tests, and circulating tumor cell tests, are often employed for screening and monitoring. Additionally, specific tests like Pap smears and HPV tests for cervical cancer, and mammography for breast cancer screening, are essential components of cancer diagnostics in India.
The cancer diagnostic market in India is a collaborative effort involving both government and private players. Government institutions like the All India Institute of Medical Sciences (AIIMS) and the Tata Memorial Centre are pivotal in research, diagnosis and treatment, serving patients from various socioeconomic backgrounds. In the private sector, major hospital chains such as Apollo Hospitals, Max Healthcare and Fortis Healthcare are key players, alongside specialized diagnostic companies like Metropolis Healthcare, Dr Lal PathLabs and Vijaya Diagnostic Centre. Additionally, international companies like Siemens Healthineers, GE Healthcare and Philips Healthcare contribute advanced technologies and expertise to the Indian market. The burgeoning market has also witnessed the emergence of various startups across India such as OncoStem Diagnostics and PredOmix, which are bringing next generation expertise and tools in cancer diagnosis.
Along with these, domestic academic institutions and research organizations have also been key driving forces behind the tremendous innovation and development observed in the Indian cancer diagnostic tests market. The International Institute of Information Technology (IIIT), Hyderabad is one noteworthy example; in 2023, the institute announced the development of a screening tool for oral cancer. The tool was created in collaboration between iHub-Data at IIIT-H and INAI, an applied AI research center managed by IIIT-H, the Telangana government, Intel, and the Public Health Foundation of India.
The future of India's cancer diagnostic tests market looks promising for companies seeking entry, with several factors contributing to this positive outlook. This predominantly includes government initiatives like the National Cancer Control Programme and the Ayushman Bharat Scheme, which are increasing focus on cancer prevention, early detection and treatment. Further, for companies looking to enter or expand in India's cancer diagnostic marker, there is a growing emphasis on developing affordable solutions. Given the large population and diverse economic conditions in India, there is a significant opportunity for companies that can provide high quality, cost effective diagnostic tests. This focus on affordability, combined with the overall growth of the market, creates a favorable environment for both domestic and international players in the cancer diagnostics sector.
Table of Contents
1. India Cancer Diagnostic Tests Market Overview
- 1.1 Current Market Scenario
- 1.2 Future Market Opportunities
2. India Cancer Diagnostic Tests Market Business Models
- 2.1 Hospitals
- 2.2 Private Diagnostic Labs
3. Lung Cancer Diagnosis in India
- 3.1 Market Overview
- 3.2 Tests Availability & Pricing
4. Prostate Cancer Diagnosis in India
- 4.1 Market Overview
- 4.2 Tests Availability & Pricing
5. Cervical Cancer Diagnosis in India
- 5.1 Market Overview
- 5.2 Tests Availability & Pricing
6. Breast Cancer Diagnosis in India
- 6.1 Market Overview
- 6.2 Tests Availability & Pricing
7. Oral Cancer Diagnosis in India
- 7.1 Market Overview
- 7.2 Tests Availability & Pricing
8. Stomach Cancer Diagnosis in India
- 8.1 Market Overview
- 8.2 Tests Availability & Pricing
9. Pancreatic Cancer Diagnosis in India
- 9.1 Market Overview
- 9.2 Tests Availability & Pricing
10. Hepatocellular Cancer Diagnosis in India
- 10.1 Market Overview
- 10.2 Tests Availability & Pricing
11. Colorectal Cancer Diagnosis in India
- 11.1 Market Overview
- 11.2 Tests Availability & Pricing
12. Hematological Cancers Diagnosis in India
- 12.1 Market Overview
- 12.2 Tests Availability & Pricing
13. India Cancer Diagnostic Tests Market Dynamics
- 13.1 Market Drivers & Opportunities
- 13.2 Market Challenges & Restraints
14. Competitive Landscape
- 14.1 Aarthi Scans and Labs
- 14.2 Apollo Diagnostics (Apollo Health and Lifestyle Limited)
- 14.3 DNA Forensics Laboratory
- 14.4 DNA Labs India
- 14.5 Dr. Lal PathLabs
- 14.6 Fortis Healthcare Limited
- 14.7 Ganesh Diagnostic
- 14.8 Pathkind Labs
- 14.9 Tata Memorial Center
- 14.10 Vijaya Diagnostic Center
List of Tables
- Table 1-1: Cancer Diagnostic Tests - Major Players by City
- Table 3-1: Lung Cancer - CEA Antigen Test Costs (INR/US$), August'2024
- Table 3-2: Lung Cancer - SCC-TA4 Antigen Test Costs (INR/US$), August'2024
- Table 3-3: Lung Cancer - CA125 Antigen Test Costs (INR/US$), August'2024
- Table 3-4: Lung Cancer - CYFRA 21 Antigen Test Costs (INR/US$), August'2024
- Table 5-1: Cervical Cancer - CA19.9 Antigen Test Costs (INR/US$), August'2024
- Table 5-2: Cervical Cancer - CA125 Antigen Test Costs (INR/US$), August'2024
- Table 5-3: Cervical Cancer - CEA Antigen Test Costs (INR/US$), August'2024
- Table 5-4: Cervical Cancer - CA15.3 Antigen Test Costs (INR/US$), August'2024
- Table 6-1: Breast Cancer - CA15.3 Antigen Test Costs (INR/US$), August'2024
- Table 6-2: Breast Cancer - CEA Antigen Test Costs (INR/US$), August'2024
- Table 6-3: Breast Cancer - CA125 Antigen Test Costs (INR/US$), August'2024
- Table 6-4: Breast Cancer - CA27.29 Antigen Test Costs (INR/US$), August'2024
- Table 6-5: Breast Cancer - Ki-67 Antigen Test Costs (INR/US$), August'2024
- Table 7 1: Oral Cancer - CA125 Antigen Test Costs (INR/US$), August'2024
- Table 8-1: Stomach Cancer - CA 19.9 Antigen Test Costs (INR/US$), August'2024
- Table 8-2: Stomach Cancer - CA 72.4 Antigen Test Costs (INR/US$), August'2024
- Table 8-3: Stomach Cancer - CEA Antigen Test Costs (INR/US$), August'2024
- Table 9-1: CA 19.9 Pancreatic Cancer Marker - Test Cost via MediFee by City (US$/INR), August'2024
- Table 9-2: Pancreatic Cancer - CA19.9 Antigen Test Costs (INR/US$), August'2024
- Table 9-3: Pancreatic Cancer - CEA Antigen Test Costs (INR/US$), August'2024
- Table 10-1: Serum AFP - Test Cost via MediFee by City (US$/INR), August'2024
- Table 10-2: Hepatocellular Cancer - Alpha Fetoprotein Antigen Test Costs (INR/US$), August'2024
- Table 10-3: Hepatocellular Cancer - CEA Antigen Test Costs (INR/US$), August'2024
- Table 10-4: Hepatocellular Cancer - PIVKA-2 Antigen Test Costs (INR/US$), August'2024
- Table 10-5: Hepatocellular Cancer - Ferritin Antigen Test Costs (INR/US$), August'2024
- Table 11-1: Colorectal Cancer - CA19.9 Antigen Test Costs (INR/US$), August'2024
- Table 11-2: Colorectal Cancer - CEA Antigen Test Costs (INR/US$), August'2024
- Table 12-1: Hematological Cancers - CD19 Antigen Test Costs (INR/US$), August'2024
- Table 12-2: Hematological Cancers - CD22 Antigen Test Costs (INR/US$), August'2024
- Table 12-3: Hematological Cancers - CD33 Antigen Test Costs (INR/US$), August'2024
List of Figures
- Figure 1-1: India - Estimated Cancer Cases, 2024-2028
- Figure 1-2: India - Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 1-3: India Cancer Diagnostic Tests Market Current Scenario
- Figure 1-4: India Cancer Diagnostic Tests Market Future Opportunities
- Figure 2 1: Hospital as a Cancer Diagnostic Test Business Model - Aspects
- Figure 2 2: Private Diagnostic Labs as a Cancer Diagnostic Test Business Model - Aspects
- Figure 3-1: India - Estimated Lung Cancer Cases, 2024-2028
- Figure 3-2: Lung Cancer Diagnostic Tests Available in India
- Figure 3-3: India - Lung Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 3-4: India - Chest CT Scan Cost (US$/INR), August'2024
- Figure 3-5: Chest CT Scan - Cost by Scan Type via MFine (US$/INR), August'2024
- Figure 3-6: Lung Biopsy - Cost at King George's Medical University by Test Type (US$/INR), August'2024
- Figure 3-7: India - Lung Cancer Panel Test Cost (US$/INR), August'2024
- Figure 4-1: India - Estimated Prostate Cancer Cases, 2024-2028
- Figure 4-2: India - Prostate Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 4-3: Prostate Cancer Diagnostic Tests Available in India
- Figure 4-4: India - Prostate Cancer Diagnostic Tests Availability
- Figure 4-5: India - Prostate Cancer Diagnostic Testing Challenges
- Figure 4-6: India - Prostate Cancer Diagnostic Tests Market Opportunities
- Figure 4-7: India - PSA Test Cost (INR/US$), August'2024
- Figure 4-8: India - Prostate Cancer Screening Package Cost (US$/INR), August'2024
- Figure 4-9: Ganesh Diagnostic & Imaging Center (GDIC) - Prostate Cancer Preventive Package Cost Breakdown (US$/INR), August'2024
- Figure 4-10: India - Prostate Health Index Test Cost (US$/INR), August'2024
- Figure 4-11: India - TRUS Guided Prostate Biopsy Scan Cost (US$/INR), August'2024
- Figure 4-12: India - Prostate Cancer Screening Package Cost (US$), August'2024
- Figure 5-1: India - Estimated Cervical Cancer Cases, 2024-2028
- Figure 5-2: India - Cervical Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 5-3: Cervical Cancer Diagnostic Tests Available in India
- Figure 5-4: India - Pap Smear Test Cost (US$/INR), August'2024
- Figure 5-5: India - LBC PAP Smear Test Cost (US$/INR), August'2024
- Figure 5-6: India - HPV DNA Test Cost (US$/INR), August'2024
- Figure 5-7: HPV DNA Test - Cost at Metropolis Healthcare by City (US$/INR), August'2024
- Figure 5-8: India - Cervical Cancer Package Costs (US$/INR), August'2024
- Figure 5-9: India - Cervical Biopsy Costs (US$/INR), August'2024
- Figure 5-10: India - Cervical Colposcopy Costs (US$/INR), August'2024
- Figure 6-1: India - Estimated Breast Cancer Cases, 2024-2028
- Figure 6-2: India - Breast Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 6-3: Breast Cancer Diagnostic Tests Available in India
- Figure 6-4: India - Breast Cancer Diagnostic Tests Market Opportunities
- Figure 6-5: India - Breast Ultrasound Cost (US$/INR), August'2024
- Figure 6-6: India - Breast Mammography Cost (US$/INR), August'2024
- Figure 6-7: Breast Mammography - Cost by City (US$), August'2024
- Figure 6-8: India - Breast Care Package Cost (US$/INR), August'2024
- Figure 7-1: India - Estimated Oral Cancer Cases, 2024-2028
- Figure 7-2: India - Oral Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 7-3: Oral Cancer Diagnostic Tests Available in India
- Figure 7-4: India - Neck CT Scan Cost (US$/INR), August'2024
- Figure 7-5: Dental CT Scan - Cost at House of Diagnostics by Type (US$/INR), August'2024
- Figure 7-6: India - Oral Cancer Test Package Cost (US$/INR), August'2024
- Figure 8-1: India - Estimated Stomach Cancer Cases, 2024-2028
- Figure 8-2: India - Stomach Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 8-3: Stomach Cancer Diagnostic Tests Available in India
- Figure 8-4: India - Whole Abdomen CT Scan Cost (US$/INR), August'2024
- Figure 8-5: India - Abdomen Ultrasound Cost (US$/INR), August'2024
- Figure 8-6: Stomach Marker Profile Test - Cost at Metropolis Healthcare by City (US$/INR), August'2024
- Figure 8-7: India - Gastric Cancer Test Package Cost (US$/INR), August'2024
- Figure 8-8: India - CA 72 4 Gastric Cancer Marker Test Cost (US$/INR), August'2024
- Figure 9-1: India - Estimated Pancreatic Cancer Cases, 2024-2028
- Figure 9-2: India - Pancreatic Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 9-3: Pancreatic Cancer Diagnostic Tests Available in India
- Figure 9-4: India - Hereditary Cancer Panel Test Costs (US$/INR), August'2024
- Figure 9-5: India - CA 19.9 Pancreatic Cancer Marker Test Cost (US$/INR), August'2024
- Figure 9-6: CA 19.9 Pancreatic Cancer Marker - Test Cost via MediFee by City (US$/INR), August'2024
- Figure 9-7: India - Whole Abdomen CT Scan Cost (US$/INR), August'2024
- Figure 9-8: India - Abdomen Ultrasound Cost (US$/INR), August'2024
- Figure 9-9: Ganesh Diagnostic & Imaging Center (GDIC) - Pancreatic Cancer Preventive Package Cost Breakdown (US$/INR), August'2024
- Figure 10-1: India - Estimated Hepatocellular Cancer Cases, 2024-2028
- Figure 10-2: India - Hepatocellular Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 10-3: Hepatocellular Cancer Diagnostic Tests Available in India
- Figure 10-4: India - Serum AFP Marker Test Costs (US$/INR), August'2024
- Figure 10-5: India - Serum AFP - Test Cost via MediFee by City (US$/INR), August'2024
- Figure 10-6: India - Hepatocellular Cancer Marker Profile Costs (US$/INR), August'2024
- Figure 10-7: Ganesh Diagnostic & Imaging Center (GDIC) - Hepatocellular Cancer Package Cost Breakdown (US$/INR), August'2024
- Figure 11-1: India - Estimated Colorectal Cancer Cases, 2024-2028
- Figure 11-2: India - Colorectal Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 11-3: Colorectal Cancer Diagnostic Tests Available in India
- Figure 11-4: India - Fecal Occult Blood Test (FOBT) Costs (US$/INR), August'2024
- Figure 11-5: India - Fecal Immunochemical Test (FIT) Costs (US$/INR), August'2024
- Figure 11-6: Ganesh Diagnostic & Imaging Center (GDIC) - Colorectal Cancer Package Cost Breakdown (US$/INR), August'2024
- Figure 12-1: India - Estimated Hematological Cancer Cases, 2024-2028
- Figure 12-2: India - Hematological Cancer Diagnostic Tests Market Opportunity (INR Crore/US$ Million), 2024-2028
- Figure 12-3: Hematological Cancer Diagnostic Tests Available in India
- Figure 12-4: India - Complete Blood Count Test Cost (US$/INR), August'2024
- Figure 12-5: India - Comprehensive Leukemia Panel Cost (US$/INR), August'2024
- Figure 13-1: India Cancer Diagnostic Tests Market Drivers & Opportunities
- Figure 13-2: India Cancer Diagnostic Tests Market Challenges & Restraints
